Clarius Group, LLC Edwards Lifesciences Corp Transaction History

Clarius Group, LLC

$1.4 Billion
Q3 2024

A detailed history of Clarius Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Clarius Group, LLC holds 4,443 shares of EW stock, worth $301,057. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,443

Previous 4,551 2.37%

Holding current value

$301,057

Previous $420,000 30.24%

% of portfolio

0.02%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$59.7 - $93.78 $6,447 - $10,128	-108 Reduced 2.37%	4,443 $293,000
Q2 2024 Jul 11, 2024	SELL	$84.3 - $94.31 $9,357 - $10,468	-111 Reduced 2.38%	4,551 $420,000
Q1 2024 Apr 17, 2024	SELL	$72.54 - $95.56 $47,658 - $62,782	-657 Reduced 12.35%	4,662 $445,000
Q4 2023 Jan 29, 2024	SELL	$61.71 - $77.76 $77,014 - $97,044	-1,248 Reduced 19.0%	5,319 $405,000
Q3 2023 Oct 19, 2023	SELL	$69.28 - $93.38 $138,767 - $187,040	-2,003 Reduced 23.37%	6,567 $454,000
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $31,668 - $36,694	389 Added 4.75%	8,570 $808,000
Q1 2023 Apr 17, 2023	BUY	$74.26 - $84.51 $14,703 - $16,732	198 Added 2.48%	8,181 $676,000
Q4 2022 Jan 25, 2023	SELL	$68.3 - $87.44 $4,507 - $5,771	-66 Reduced 0.82%	7,983 $596,000
Q3 2022 Oct 24, 2022	SELL	$82.37 - $107.29 $4,859 - $6,330	-59 Reduced 0.73%	8,049 $665,000
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $98,091 - $145,458	1,134 Added 16.26%	8,108 $771,000
Q4 2021 Feb 02, 2022	BUY	$106.37 - $130.68 $6,275 - $7,710	59 Added 0.85%	6,974 $903,000
Q3 2021 Oct 18, 2021	BUY	$102.91 - $122.75 $26,550 - $31,669	258 Added 3.88%	6,915 $783,000
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $7,629 - $9,533	91 Added 1.39%	6,657 $689,000
Q1 2021 Apr 27, 2021	BUY	$78.68 - $90.67 $27,380 - $31,553	348 Added 5.6%	6,566 $549,000
Q4 2020 Jan 15, 2021	BUY	$71.69 - $91.23 $88,035 - $112,030	1,228 Added 24.61%	6,218 $567,000
Q3 2020 Oct 09, 2020	BUY	$67.19 - $87.44 $21,635 - $28,155	322 Added 6.9%	4,990 $398,000
Q2 2020 Jul 08, 2020	BUY	$57.54 - $76.95 $183,955 - $246,009	3,197 Added 217.34%	4,668 $323,000
Q1 2020 Apr 24, 2020	SELL	$52.41 - $81.0 $3,563 - $5,508	-68 Reduced 4.42%	1,471 $277,000
Q4 2019 Jan 22, 2020	SELL	$71.7 - $82.09 $4,875 - $5,582	-68 Reduced 4.23%	1,539 $364,000
Q3 2019 Oct 23, 2019	BUY	$61.55 - $75.43 $16,003 - $19,611	260 Added 19.3%	1,607 $353,000
Q2 2019 Aug 02, 2019	BUY	$55.74 - $64.41 $10,925 - $12,624	196 Added 17.03%	1,347 $249,000
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $55,121 - $73,721	1,151 New	1,151 $220,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Edwards Lifesciences Corp Transaction History